A survey on migraine attack treatment with the CEFALY® device in regular users
Sophie Penning, Jean Schoenen, Sophie Penning, Jean Schoenen
No abstract availableKeywords: Acute migraine treatment; Cefaly®; External trigeminal neurostimulation.
Conflict of interest statement
Conflict of interestS. Penning PhD is an employee of, J. Schoenen MD, PhD a consultant for Cefaly Technology.
Ethics and consent to participateThe study was performed according to the declaration of Helsinki, approved by the Citadelle Hospital-Liège-B ethics committee (No. 412) and registered on ClinicalTrials.gov (identifier: NCT02616978). No specific consent was obtained from participants, as this was an e-mail questionnaire survey in which participation was on a voluntary basis and responses to the questionnaire were anonymized on reception. The database is available on request at jschoenen@ulg.ac.be.
Figures
Flow chart of the study protocol
References
- Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gérard P, Magis D. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697–704. doi: 10.1212/WNL.0b013e3182825055.
- Magis D, Sava S, d’Elia TS, Baschi R, Schoenen J. Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2313 headache sufferers in the general population. J Headache Pain. 2013;14:95. doi: 10.1186/1129-2377-14-95.
- Gérardy PY, Fabry D, Fumal A, Schoenen J. A pilot study on supra-orbital surface electrotherapy in migraine. Cephalalgia. 2009;29(1):1101–1172.
- Kozminski M. Transcutaneous supraorbital nerve stimulation as a rescue therapy. Headache. 2014;54(S1):12.
- SurveyMonkey. . Accessed 16 Oct 2015
Source: PubMed